Funding, News and Announcements

Brain Canada and CQDM are joining forces once again to support interprovincial collaborative biopharmaceutical research and development (R&D) projects on the brain. This partnership creates a unique funding opportunity that brings together experts from academia and industry to support the development of platforms, tools and biopharmaceuticals that will pave the way for new advances in the prevention, diagnosis and treatment of brain disorders. 

This award is intended for research teams with a minimum of two independent researchers, a principal investigator from a research institution in Quebec and an independent researcher from a research institution in another Canadian province. They must work in close collaboration with at least one Quebec small and medium-sized enterprise (SME).   

The project’s budget must be between $500,000 and $2 million. 

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to the funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups. 

Click here to view the Request for Applications.  

Deadline to notify CQDM of intent to apply: August 8, 2024 
Deadline for receipt of Applications: August 15, 2024 at 6pm AST 

The grants facilitator for your faculty can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.